BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Hypothalamus
,
Alcohol
,
Trichostatin A
,
rs4950928
,
CXCL2
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
csf3r protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of CSF3R Mutations in B-Lineage Acute Lymphoblastic Leukemia Using Comprehensive Canc…
Inherited transmission of the CSF3R T618I mutation: a familial report.
Integrated transcriptome, proteome and single-cell sequencing uncover the prognostic and immunologic…
CSF3R P733T is a deleterious germline variant in acute leukaemia showing gain-of-function-like T618I…
A Case of Chronic Eosinophilic Leukemia with CSF3R-Mutant Clone and Transformed to Secondary Acute M…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Followin…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ